NYSTATIN AND TRIAMCINOLONE ACETONIDE Drug Patent Profile
✉ Email this page to a colleague
When do Nystatin And Triamcinolone Acetonide patents expire, and what generic alternatives are available?
Nystatin And Triamcinolone Acetonide is a drug marketed by Alembic, Alpharma Us Pharms, Amneal, Crown Labs Inc, Dr Reddys, Fougera Pharms Inc, Glenmark Pharms Ltd, Lupin Ltd, Macleods Pharms Ltd, Padagis Israel, Perrigo New York, Pharmafair, Taro, Torrent, Chartwell Rx, Epic Pharma Llc, Pai Holdings Pharm, Rising, Strides Pharma, and Zydus Lifesciences. and is included in thirty-one NDAs.
The generic ingredient in NYSTATIN AND TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystatin And Triamcinolone Acetonide
A generic version of NYSTATIN AND TRIAMCINOLONE ACETONIDE was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
Summary for NYSTATIN AND TRIAMCINOLONE ACETONIDE
US Patents: | 0 |
Applicants: | 20 |
NDAs: | 31 |
Finished Product Suppliers / Packagers: | 22 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NYSTATIN AND TRIAMCINOLONE ACETONIDE at DailyMed |
Pharmacology for NYSTATIN AND TRIAMCINOLONE ACETONIDE
Drug Class | Corticosteroid Polyene Antifungal |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for NYSTATIN AND TRIAMCINOLONE ACETONIDE
US Patents and Regulatory Information for NYSTATIN AND TRIAMCINOLONE ACETONIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 206785-001 | Dec 29, 2016 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Strides Pharma | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 210077-001 | Jan 29, 2018 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Alembic | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 214090-001 | Mar 31, 2021 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Crown Labs Inc | NYSTATIN AND TRIAMCINOLONE ACETONIDE | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 207731-001 | Dec 26, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |